Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study-Reference-Cited by-同舟云学术

Association between Inhaled β2-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study

Published:2022-05 Issue: Volume:Volume 17 Page:1205-1217
ISSN:1178-2005
Container-title:International Journal of Chronic Obstructive Pulmonary Disease
language:en
Short-container-title:COPD

Author:

Amegadzie Joseph Emil^ORCID,Gamble John-Michael^ORCID,Farrell Jamie^ORCID,Gao Zhiwei^ORCID

Publisher

Informa UK Limited

Subject

General Earth and Planetary Sciences,General Environmental Science

Reference54 articles.

1. GINA. Global initiative for Asthma; 2020. Available from: https://ginasthma.org/wp-content/uploads/2020/06/GINA-2020-report_20_06_04-1-wms.pdf. Accessed December 29, 2020.

2. GOLD. COPD gold guidelines; 2020. Available from: https://goldcopd.org/wp-content/uploads/2020/03/GOLD-2020-POCKET-GUIDE-ver1.0_FINAL-WMV.pdf. Accessed December 30, 2020.

3. Beta-Adrenergic Agonists

4. β2-Agonist Therapy in Lung Disease

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice;Current Opinion in Pulmonary Medicine;2023-12-12

2. High use of short-acting β₂-agonists in COPD is associated with an increased risk of exacerbations and mortality;ERJ Open Research;2023-05

3. Cardiovascular disease in asthma patients: From mechanisms to therapeutic implications;Kardiologia Polska;2023-03-27

4. Asthma and cardiovascular disease: A bidirectional association?;Respirology;2023-02-07

5. Morbidity and Mortality Associated with Chronic Obstructive Pulmonary Disease (COPD);Journal of Insurance Medicine;2023-01-01